Comment on "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline'' [J Neurooncol 2014; 118: 435-460]

被引：5
作者：
Booth, Thomas C. [1 ]
Waldman, Adam D. [2 ]
Jefferies, Sarah [3 ]
Jaeger, Rolf [4 ]
机构：
[1] Kings Coll Hosp London, London, England
[2] Univ London Imperial Coll Sci Technol & Med, London, England
[3] Addenbrookes Hosp, Cambridge, England
[4] Inst Neurol, London WC1N 3BG, England
来源：
JOURNAL OF NEURO-ONCOLOGY | 2015年 / 121卷 / 02期
基金：
英国医学研究理事会;
关键词：
RADIATION-THERAPY; PSEUDOPROGRESSION; TEMOZOLOMIDE; CONCOMITANT; PERFUSION; RADIOTHERAPY; DIAGNOSIS; SURVIVAL; NECROSIS; PREDICT;
D O I：
10.1007/s11060-014-1649-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：423 / 424
页数：2
相关论文
共 14 条
  • [1] Booth T.C., 2011, NEUROGRAPHICS, V01, P108, DOI DOI 10.3174/NG.3110014
  • [2] MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
    Brandes, Alba A.
    Franceschi, Enrico
    Tosoni, Alicia
    Blatt, Valeria
    Pession, Annalisa
    Tallini, Giovanni
    Bertorelle, Roberta
    Bartolini, Stefania
    Calbucci, Fabio
    Andreoli, Alvaro
    Frezza, Giampiero
    Leonardi, Marco
    Spagnolli, Federica
    Ermani, Mario
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2192 - 2197
  • [3] Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
    Brandsma, Dieto
    Stalpers, Lukas
    Taal, Walter
    Sminia, Peter
    van den Bent, Martinj
    [J]. LANCET ONCOLOGY, 2008, 9 (05) : 453 - 461
  • [4] Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
    Chamberlain, Marc C.
    Glantz, Michael J.
    Chalmers, Lisa
    Van Horn, Alixis
    Sloan, Andrew E.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2007, 82 (01) : 81 - 83
  • [5] Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Radiation Therapy and Concomitant Temozolomide: Comparison Study of Standard and High-b-Value Diffusion-weighted Imaging
    Chu, Hee Ho
    Choi, Seung Hong
    Ryoo, Inseon
    Kim, Soo Chin
    Yeom, Jeong A.
    Shin, Hwaseon
    Jung, Seung Chai
    Lee, A. Leum
    Yoon, Tae Jin
    Kim, Tae Min
    Lee, Se-Hoon
    Park, Chul-Kee
    Kim, Ji-Hoon
    Sohn, Chul-Ho
    Park, Sung-Hye
    Kim, Il Han
    [J]. RADIOLOGY, 2013, 269 (03) : 831 - 840
  • [6] Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Ferumoxytol versus Gadoteridol and Correlation with Survival
    Gahramanov, Seymur
    Muldoon, Leslie L.
    Varallyay, Csanad G.
    Li, Xin
    Kraemer, Dale F.
    Fu, Rongwei
    Hamilton, Bronwyn E.
    Rooney, William D.
    Neuwelt, Edward A.
    [J]. RADIOLOGY, 2013, 266 (03) : 842 - 852
  • [7] Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status
    Kong, D. -S.
    Kim, S. T.
    Kim, E. -H.
    Lim, D. H.
    Kim, W. S.
    Suh, Y. -L.
    Lee, J. -I.
    Park, K.
    Kim, J. H.
    Nam, D. -H.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2011, 32 (02) : 382 - 387
  • [8] Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma
    Mangla, Rajiv
    Singh, Gurshawn
    Ziegelitz, Doerthe
    Milano, Michael T.
    Korones, David N.
    Zhong, Jianhui
    Ekholm, Sven E.
    [J]. RADIOLOGY, 2010, 256 (02) : 575 - 584
  • [9] Ryken TC, 2014, J NEURO-ONCOL, V118, P435, DOI 10.1007/s11060-013-1330-0
  • [10] The Concepts, Diagnosis and Management of Early Imaging Changes after Therapy for Glioblastomas
    Sanghera, P.
    Rampling, R.
    Haylock, B.
    Jefferies, S.
    McBain, C.
    Rees, J. H.
    Soh, C.
    Whittle, I. R.
    [J]. CLINICAL ONCOLOGY, 2012, 24 (03) : 216 - 227
12